Javelin leadership team
Brian Pulliam, PhD
Co-Founder and CEO
Head of Informatics
Former Genentech Head of Medical Affairs Strategy, Portfolio Management, and Medical Affairs Chief of Staff
Former Genentech Head of Medical Affairs Strategy, Portfolio Management, and Medical Affairs Chief of Staff
Richard Ho, PhD
Co-Founder
Head of Strategy
20 years of industry experience, led Medical Affairs Scientific Collaboration, Field Medical, and Innovation teams at Genentech
20 years of industry experience, led Medical Affairs Scientific Collaboration, Field Medical, and Innovation teams at Genentech
Karl Simmons
Co-Founder and CTO
Head of Product and People
Founder of Cello Development Corporation and GridSpeak Corporation, 25+ years experience in the development of mission-critical high availability enterprise systems
Founder of Cello Development Corporation and GridSpeak Corporation, 25+ years experience in the development of mission-critical high availability enterprise systems
Dannis Chang, PharmD
Co-Founder
Head of Partnerships
Built and led Medical Communications and Information teams at Genentech, Halozyme, Myovant Sciences, and Mirati Therapeutics
Built and led Medical Communications and Information teams at Genentech, Halozyme, Myovant Sciences, and Mirati Therapeutics
Our experience
Strategy
50+
Over 50 years of biotechnology experience at large and small companies
20+
Over 20 product launches in primary and specialty care within global and US-specific teams
Extensive knowledge and appreciation of roles and corresponding needs
Operations
Data analysis and analytics expertise
Comprehensive artificial intelligence and systems engineering capabilities
Deep background in medical and clinical departments, including processes and programs
Gene therapy
Accustomed to the challenges and complexities with gene therapy development through every stage of the life cycle
Honed methods for identification and education
Successful approaches to development, research, and launch
Rare disease
Achieved success in launching rare therapies through aligning medical teams
Accelerated study enrollment
Defined the patient experience, journey, and barriers. Identified intervention strategies for optimal patient outcomes